ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) (NCT04363684)
🩺 Plain-English Summary (8th-Grade Level)
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
Who can join: Review the eligibility criteria below.
Location: University of Alabama Birmingham — Birmingham, Alabama
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (27 Sites)
Showing the first 25 of 27 sites.
- University of Alabama Birmingham — Birmingham, Alabama
- University of California, Los Angeles — Los Angeles, California
- University of California, San Diego — San Diego, California
- University of California San Francisco — San Francisco, California
- University of Colorado Denver — Denver, Colorado
- Mayo Clinic Florida — Jacksonville, Florida
- Emory University — Atlanta, Georgia
- Northwestern University — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Johns Hopkins University — Baltimore, Maryland
- NIH — Bethesda, Maryland
- Massachusetts General Hospital — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Mayo Clinic Rochester — Rochester, Minnesota
- Washinton University in St. Louis — St Louis, Missouri
- Cleveland Clinic Lou Ruvo Center for Brain Health — Las Vegas, Nevada
- Mount Sinai — New York, New York
- Columbia University — New York, New York
- University of North Carolina, Chapel Hill — Chapel Hill, North Carolina
- Case Western Reserve Medical Center — Cleveland, Ohio
- University of Pennsylvania — Philadelphia, Pennsylvania
- Vanderbilt University — Nashville, Tennessee
- Nantz National Alzheimer Center Houston — Houston, Texas
- UT San Antonio Health Science Center — San Antonio, Texas
- University of Washington — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (507) 293-9577
Email: forsberg.leah@mayo.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Frontotemporal Lobar Degeneration (FTLD)
Explore by condition: All Frontotemporal Lobar Degeneration (FTLD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.